Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Qlucore AB. (1/21/20). "Press Release: Qlucore Moves into New Business Areas and Expands Board".

Organisation Organisation Qlucore AB
  Group Qlucore (Group)
Product Product Qlucore Omics Explorer s/w
Persons Person Ivarsson, Carl-Johan (Qlucore AB 201209 CEO + Co-founder)
  Person 2 Lundberg, Olle (GLD Invest 201210 CEO)

Qlucore, a world leader in the development of bioinformatics software, is expanding into the area of precision medicine and precision diagnostics. In order to finance the expansion Qlucore has recently finalized a rights issue of 400k Euros and is pleased to announce two new members of the Board.

Qlucore has created a software platform for precision medicine and diagnostics, building on the development and success of Qlucore Omics Explorer which is now used by researchers in more than 35 countries. The first generation of the new software platform supports analysis and visualization of socalled fusion genes that play important roles in the diagnosis and treatment of cancer forms, such as acute lymphoblastic leukaemia and non-small cell lung cancer. Future versions will include classifiers that will assist physicians and pathologists to classify a sample in subgroups using gene expression signatures.

This new software platform comes as Qlucore recently celebrated a decade of helping researchers to visualize and analyze their data with Qlucore Omics Explorer software. Qlucore’s software combines powerful statistical methods with real time and makes it possible to interactively explore and analyze multivariate data sets, from small to very large, as well as data generated with NGS technologies.

Increasingly data generated with NGS technologies is being utilized in clinical settings. “It is a natural development that the data that our research customers have worked with using Qlucore Omics Explorer for several years is now ready to be moved into clinical use. The lack of software solutions is apparent and with our experience we will fill that gap”, says Carl-Johan Ivarsson, Qlucore President.

Alongside the move into precision medicine and diagnostics comes a rights issue of 400k Euros and the appointment of Johan Thiel and Boel Sundvall to the Board. The pair join existing Board members Pia Gideon, Magnus Fontes, Thoas Fioretos, Carl-Johan Ivarsson and Olle Lundberg.

Boel has an MSc in Business and Economics from the Stockholm School of Economics and has held senior management positions in several companies listed in Sweden. She has broad experience from several industries, with a background in Finance, Corporate Finance, Investor Relations and Communications. On her new appointment Boel said “To continue to develop Qlucore with the team is very exciting and I am looking forward to it.”

Johan Thiel is an entrepreneur with a passion for building business and creating value, and for the past six years has been a CEO focusing on Sales and Marketing, Manufacturing and Product Development. “I strongly believe in a collaborative sharing style where true partnership brings success to all involved. This results in many positive effects for the brand; progress, growth, satisfied clients and consumers with products that have more value and make a difference.”

About Qlucore

Qlucore ( is a leading provider of a new generation intuitive bioinformatics software. The Qlucore software combines powerful statistical methods with real time visualization. This shortens analysis time, adds more creativity to the research process, strengthens the path to new findings and facilitates easier and more fruitful collaboration between biologists and bioinformaticians.

The Qlucore Omics Explorer software makes it possible to interactively explore and analyze multivariate data sets, from small to very large as well as data generated with NGS technologies. The new NGS Module is an add on to Qlucore Omics Explorer, consisting of an interactive Genome browser and flexible and interactive filter options. One of the key features is to enable synchronization between the expression analysis of RNA-seq data and genomic information, making researchers even more productive.

Qlucore was founded in 2007 by leading researchers at the Departments of Mathematics and Clinical Genetics at Lund University, Sweden. Today Qlucore has customers in about 35 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. Many of the leading pharmaceutical companies use Qlucore in their research, as well as hospitals and universities around the world.

Press Contact:
Qlucore Contact:
Chaz Brooks / Alison Scarrott
Tel: +44 (0)1483 537 890

Record changed: 2023-06-05


Picture Berlin Partner Special Topic HealthCapital Berlin-Brandenburg 650x200px

More documents for Qlucore (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top